According to the regulations of the Ministry of Health in Circular No. 39/2024/TT-BYT dated November 17, 2024 amending and supplementing a number of articles of Circular No. 35/2016/TT-BYT dated September 28, 2016 of the Minister of Health promulgating the List and rates, conditions for payment for medical technical services within the scope of enjoyment of health insurance participants, the HbA1c (blood) quantitative test to determine treatment regimens or evaluate the results of diabetes treatment is paid by health insurance from the 2nd time onwards, at least every 90 ± 3 days.
The doctor's prescription for testing is based on the patient's medical history and course of events. To perform the test, it is recommended that patients when going for examination proactively exchange directly with the treating doctor to have a prescription for testing suitable to the health insurance payment conditions according to the regulations of the Ministry of Health.
According to Circular No. 26/2025/TT-BYT issued by the Ministry of Health, effective from July 1, 2025, patients with some chronic diseases on the permitted list will be prescribed outpatient drugs for more than 30 days, instead of the maximum limit of 30 days as before.
Accordingly, the list of diseases and groups of diseases applied for outpatient prescriptions for more than 30 days is issued by the Ministry of Health. Specifically, there are 16 disease groups, including: infections, parasites; blood diseases; mental illnesses; endocrine, nutritional and metabolic diseases.
Common chronic diseases that are given medicine for more than 30 days include: hypertension, diabetes, bronchial asthma, COPD, anxiety disorders, depression; chronic hepatitis B, HIV/AIDS, hypothyroidism, pituitary insufficiency, Parkinson's disease, Alzheimer's disease, dementia; blood and immune diseases such as Thalassemia, spinal cord stiffness with muscle atrophy; along with some minor gynecological diseases such as puberty. This list has a total of 252 diseases.
Whether medication is provided for more than 30 days depends on the clinical condition and stability of the patient. On that basis, the doctor will decide the maximum number of days of medication use, but not exceeding 90 days.
